Risk factors for myopia progression in second-grade primary school children in Taipei: a population-based cohort study (see page 1611) A quarter of myopic children in the second grade of school in Taipei had greater than or equal to one diopter of myopic progression in 1 year. Close reading distance and greater baseline spherical equivalent refractive error were associated with faster myopic progression.
Myopic glaucomatous eyes with or without optic disc shape alteration: a longitudinal study (see page 1618)
The features of glaucoma progression in myopic eyes were different between eyes with an optic disc shape alteration, particularly optic disc tilt, and eyes with a normal-appearing optic disc.
Safety and efficacy of a low-cost glaucoma drainage device for refractory childhood glaucoma (see page 1623) The Aurolab Aqueous Drainage Implant (AADI) is similar to the Baerveldt Glaucoma Implant, costs a fraction of the amount and preliminary results indicate a good efficacy and safety profile. The AADI could be a a viable low cost solution for poor patients with refractory glaucoma. Nasalised distribution of peripapillary retinal nerve fibre layers in large discs (see page 1643) In large-sized optic discs, we observed a nasalised pattern of the peripapillary retinal nerve fibre layer distribution. This was also associated with nasalisation of the major superior temporal retinal artery position.
Long-term clinical course of normotensive preperimetric glaucoma (see page 1649)
We demonstrated that intraocular pressure plays a key role in the conversion from preperimetric glaucoma to manifest glaucoma even in eyes with normal tension glaucoma.
Epiblepharon in congenital glaucoma: case-control study (see page 1654) Congenital glaucoma patients have a high frequency of lower lid epiblepharon. Buphthalmos, initial high intraocular pressure, and corneal erosion are associated with epiblepharon. Evaluation of epiblepharon should be considered when congenital glaucoma patients have these factors.
Investigating the usefulness of a clusterbased trend analysis to detect visual field progression in patients with openangle glaucoma (see page 1658) Considerable proportion of clusters were progressing when mean total deviation trend analysis suggested no significant progression. In addition, cluster trend analysis was no worse than mean total deviation trend analysis in reliability and sensitivity performances.
Regional vascular density-visual field sensitivity relationship in glaucoma according to disease severity (see page 1666) Peripapillary vascular density using optical coherence tomography angiography showed significant association with visual field mean sensitivity (VFMS) globally and regionally in moderate to advanced glaucoma while it had a significant regional association with VFMS in mild glaucoma.
The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users
Group: Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema (see page 1673) This large real-world study demonstrates that the rate of developing treatment-requiring DMO increases sharply in the year after cataract surgery for all grades of retinopathy, peaking in the 3-6 month post-operative period. Early response to ranibizumab predictive of functional outcome after dexamethasone for unresponsive diabetic macular oedema (see page 1689) The early visual and anatomical responses after a loading dose of anti-vascular endothelial growth factor (VEGF) are predictive of long-term anatomical and functional improvement after switching to corticosteroids in patients with diabetic macular oedema. In patients responding poorly to anti-VEGF, an early shift to corticosteroids could be reasonable.
Retinal detachment surgery in western
Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab (see page 1694) Intravitreal triamcinolone acetonide was found to preserve visual acuity and decrease central foveal thickness in choroidal melanoma patients with radiation maculopathy after plaque radiotherapy recalcitrant to high-dose intravitreal bevacizumab. doi: 10.1136/bjophthalmol-2017-311555 
